Back
Virtus Diversified Income & Convertible Fund Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Buy
89
ACV
Virtus Diversified Income & Convertible Fund
Last Price:
$27.07
Seasonality Move:
-2.44%
Buy
75
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$90.03
Seasonality Move:
-24.59%
Buy
89
Virtus Diversified Income & Convertible Fund (ACV)
is a Buy
Is Virtus Diversified Income & Convertible Fund a Buy, Sell or Hold?
-
The current Virtus Diversified Income & Convertible Fund [ACV] share price is $26.81. The Score for ACV is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
-
ACV is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
75
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $95.99. The Score for DRUG is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACV Stock Price Chart
What is Virtus Diversified Income & Convertible Fund's stock price today?
-
The Virtus Diversified Income & Convertible Fund share price today is $26.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACV is experiencing slight buying pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $95.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.3 | Buy |
| Relative Strength Index (14 RSI): | 61.91 | Buy |
| Chaikin Money Flow: | 8094 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.79 - 26.59) | Buy |
| Bollinger Bands (100): | (23.6 - 26) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.7 | Buy |
| Relative Strength Index (14 RSI): | 65.61 | Buy |
| Chaikin Money Flow: | 292843 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (74.33 - 88.51) | Buy |
| Bollinger Bands (100): | (45.68 - 74.86) | Buy |
ACV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.64 | Buy |
| 20-day SMA: | 26.24 | Buy |
| 50-day SMA: | 25.78 | Buy |
| 200-day SMA: | 23.11 | Buy |
| 8-day EMA: | 26.59 | Buy |
| 20-day EMA: | 26.28 | Buy |
| 50-day EMA: | 25.74 | Buy |
| 200-day EMA: | 23.87 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 83.5 | Buy |
| 20-day SMA: | 83.91 | Buy |
| 50-day SMA: | 69.69 | Buy |
| 200-day SMA: | 45.45 | Buy |
| 8-day EMA: | 85.95 | Buy |
| 20-day EMA: | 81.76 | Buy |
| 50-day EMA: | 72.81 | Buy |
| 200-day EMA: | 51.04 | Buy |
Virtus Diversified Income & Convertible Fund Earnings Growth & ACV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.93 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.27 per share, and a decrease next year of $1.59 per share.
Virtus Diversified Income & Convertible Fund Technical Analysis
| Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||